Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients

Cancer

Volumn 86, Issue 1, 1999, Pages 126-134

  Mullen, Craig A ^a   Petropoulos, Demetrios ^a   Roberts, W Mark ^a   Rytting, Michael ^a,b   Zipf, Theodore ^a   Chan, Ka Wah ^a   Culbert, Steven J ^a   Danielson, Martha ^a   Jeha, Sima S ^a   Kuttesch, John F ^a   Rolston, Kenneth V ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b DRISCOLL CHILDREN S HOSPITAL   (United States)

Author keywords

Antibiotics; Cancer; Fever; Infectious disease therapy; Neoplastic disease; Neutropenia; Pediatrics

Indexed keywords

ACICLOVIR; AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN; AMPICILLIN; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CEFALEXIN; CEFTAZIDIME; CIPROFLOXACIN; CLINDAMYCIN; FLUCONAZOLE; VALACICLOVIR; VANCOMYCIN;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; DISEASE COURSE; FEVER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MORBIDITY; NEUTROPENIA; ORAL DRUG ADMINISTRATION; OUTPATIENT CARE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME;

ADOLESCENT; AMBULATORY CARE; ANTINEOPLASTIC AGENTS; BACTERIAL INFECTIONS; CEFTAZIDIME; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; CIPROFLOXACIN; FEMALE; FEVER; HUMANS; MALE; NEOPLASMS; NEUTROPENIA; PROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 0033168412     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990701)86:1<126::AID-CNCR18>3.0.CO;2-1     Document Type: Article

References (12)

1. Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenias. N Engl J Med 1993; 328: 1323-32.
2. Buchanan GR. Approach to treatment of the febrile cancer patient with low-risk neutropenia. Hematol Oncol Clin North Am 1993;7:919-35.
3. Rolston KVI, Rubenstein EB, Freifeld A. Early empiric antibiotic therapy for febrile neutropenia patients at low risk. Inject Dis Clin North Am 1996;10:223-37.
4. Talcott JA, Siegel RD, Finberg R, Goldman L. Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of prediction rule. J Clin Oncol 1992;10:316-22.
5. Talcott JA, Finberg R, Mayer RJ, Goldman L. The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation. Arch Intern Med 1988;148:2561-8.
6. Rackoff WR, Gonin R, Robinson C, Kreissman SG, Breitfeld PP. Predicting the risk of bacteremia in children with fever and neutropenia. J Clin Oncol 1996;14:919-24.
7. Lucas KG, Brown AE, Armstrong D, Chapman D, Heller G. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis. Cancer 1996;77:791-8.
8. Rubenstein EB, Rolston K, Benjamin RS, Loewy J, Escalante C, Manzullo E, et al. Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer. Cancer 1993;71:3640-6.
9. Talcott JA, Whalen A, Clark J, Rieker PP, Finberg R. Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule. J Clin Oncol 1994;12:107-14.
10. Malik IA, Khan WA, Karim M, Aziz Z, Khan MA. Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial. Am J Med 1995;98:224-3.
11. Mullen CA, Petropoulos D, Rytting M, Jeha S, Zipf T, Roberts WM, et al. Acute reversible arthropathy in a pediatric cancer patient treated with a short course of ciprofloxacin for febrile neutropenia. J Pediatr Hematol Oncol 1998;20:516-8.
12. Mustafa MM, Aquino VM, Pappo A, Tkaczewski I, Buchanan GR. A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteremia. J Pediatr 1996;128:847-9.